| Cancer treatment |
2023-4-25 |
2023-8-17 |
|
| Treatment of circadian rhythm disorders |
2023-3-14 |
2023-7-06 |
|
| Trichostatin a (tsa) sensitivity in the treatment of tumors |
2023-2-27 |
2023-9-07 |
|
| Method of treatment of schizophrenia |
2023-2-16 |
2023-6-22 |
|
| Treatment of circadian rhythm disorders |
2023-2-13 |
2023-5-23 |
|
| Method of treatment with tradipitant |
2023-1-18 |
2023-4-11 |
|
| Highly purified pharmaceutical grade tasimelteon |
2023-1-03 |
2023-5-18 |
|
| Administration of tasimelteon under fasted conditions |
2022-12-23 |
2023-2-16 |
|
| Prediction of severity of covid-19 and methods of treatment |
2022-12-02 |
2023-6-08 |
|
| Iloperidone metabolite for use in treatment of psychiatric disorders |
2022-12-01 |
2023-2-14 |
|
| Treatment of atopic dermatitis with tradipitant |
2022-11-07 |
2023-3-09 |
|
| Melatonin agonist treatment |
2022-10-14 |
2023-1-26 |
|
| Depot administration of iloperidone |
2022-9-27 |
2023-1-26 |
|
| Treatment of sleep disturbances in autism spectrum disorder patients |
2022-9-14 |
2023-3-23 |
|
| how to improve sleep |
2022-9-07 |
2023-8-10 |
2023-8-10 |
| Treatment of circadian rhythm disorders |
2022-9-05 |
2022-9-29 |
|
| Treatment of lower respiratory tract infection with tradipitant |
2022-8-26 |
2023-3-09 |
|
| Treatment of cyr61- and vegf-mediated conditions |
2022-8-25 |
2022-12-22 |
|
| Method for improving or enhancing cognition |
2022-8-08 |
2022-12-01 |
|
| Treatment of gastric accommodation with tradipitant |
2022-8-05 |
2023-2-16 |
|
| Treatment or prevention of sars-cov-2 infection using (s)-crizotinib |
2022-8-03 |
2023-2-09 |
|
| Antisense oligonucleotide (aso) gene inhibition and treatment |
2022-7-13 |
2023-1-19 |
|
| Tasimelteon liquid formulations and methods for their use |
2022-7-11 |
2022-7-29 |
|
| Ophthalmic pharmaceutical compositions |
2022-7-01 |
2022-9-20 |
|
| Treatment of Affective Disorders |
2022-5-26 |
2022-9-08 |
|
| Use of tradipitant in motion sickness |
2022-4-28 |
2022-8-11 |
|
| Methods for the administration of iloperidone |
2022-4-08 |
2022-8-18 |
|
| Tasimelteon for treating smith-magenis syndrome |
2022-3-14 |
2022-5-24 |
|
| Genetic markers for enhancing efficacy of antipsychotic treatment with … |
2021-11-29 |
2022-3-17 |
|
| Treatment of public speaking anxiety with an alpha-7 nicotinic acetylcholine … |
2021-11-24 |
2023-6-08 |
|
| Multiple myeloma treatment |
2021-10-15 |
2022-1-25 |
|
| METHODS OF TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY PDE IV |
2021-9-10 |
2023-4-11 |
|
| Method of treatment with tradipitant |
2021-7-08 |
2021-10-28 |
|
| Treatment of schizophrenia |
2021-6-28 |
2021-10-21 |
|
| Prediction of sleep parameter and response to sleep-inducing compound based on … |
2021-5-21 |
2021-9-09 |
|
| Method of treatment |
2021-4-13 |
2021-9-30 |
|
| Identification and use of compounds in the treatment or prevention of severe … |
2021-3-26 |
2021-11-11 |
|
| Treatment of lower respiratory tract infection with tradipitant |
2021-3-24 |
2021-9-30 |
|
| Treating neurodegenerative disease with fenofibrate and analogs thereof |
2021-3-17 |
2021-7-26 |
|
| Methods for the administration of iloperidone |
2021-3-03 |
2021-6-24 |
|
| Improved treatment of atopic dermatitis with tradipitant |
2021-2-24 |
2021-9-02 |
|
| Improving sleep or post-sleep performance |
2021-2-19 |
2021-10-25 |
|
| Depot administration of iloperidone |
2021-2-12 |
2021-6-03 |
|
| Treatment of circadian rhythm disorders |
2021-1-15 |
2021-5-06 |
|
| Use of tradipitant in motion sickness |
2020-9-28 |
2021-1-14 |
|
| Treatment of disorders with tasimelteon |
2020-8-26 |
2021-10-25 |
|
| Tasimelteon use in treating sleep aberrations |
2020-6-29 |
2022-5-04 |
|
| Improved treatment of atopic dermatitis with tradipitant. |
2020-3-12 |
2020-10-09 |
|
| IMPROVEMENT IN A METHOD FOR TREATMENT OF PATIENTS WITH A CIRCADIAN RHYTHM- … |
2020-2-13 |
2021-10-05 |
|
| Benzisoxazoles |
2019-12-26 |
2020-4-30 |
|
| Improved treatment of atopic dermatitis with tradipitant |
2019-12-20 |
2020-6-25 |
|
| Method of treatment with tradipitant |
2019-12-03 |
2020-6-11 |
|
| Melatonin agonist treatment |
2019-10-18 |
2019-11-07 |
|
| Iloperidone for the treatment of schizophrenia |
2019-9-06 |
2019-12-26 |
|
| Treatment method using tradipitant |
2019-6-06 |
2021-11-11 |
|
| Method and composition for treating a serotonin receptor-mediated condition |
2018-10-30 |
2018-11-22 |
|
| Method of predicting a predisposition to QT prolongation |
2018-4-18 |
2020-2-25 |
2020-2-25 |
| Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl] … |
2017-12-08 |
2019-3-19 |
2019-3-19 |
| Antipsychotic treatment based on snp genotypes of drd2 or ankk1 |
2017-10-06 |
2018-3-29 |
|
| Method of predicting a predisposition to QT prolongation |
2017-9-18 |
2020-2-18 |
2020-2-18 |
| Method of predicting a predisposition to QT prolongation |
2017-9-14 |
2020-2-18 |
2020-2-18 |
| Method of treatment based on polymorphisms of the KCNQ1 gene |
2017-9-14 |
2020-2-18 |
2020-2-18 |
| Method of predicting a predisposition to QT prolongation |
2017-9-14 |
2020-2-25 |
2020-2-25 |
| Method and composition for treating a serotonin receptor-mediated condition |
2016-8-19 |
2016-12-15 |
|
| Antipsychotic treatment based on SNP genotype |
2016-3-30 |
2016-10-04 |
2016-10-04 |
| Intermediate and process useful in the preparation of {2-[1-(3,5-bis- … |
2015-11-10 |
2017-7-18 |
2017-7-18 |
| Tasimelteon for treating smith-magenis syndrome |
2015-8-29 |
2021-1-06 |
|
| Optical isomers of iloperidone metabolite |
2015-8-06 |
2015-12-03 |
|
| Identification of a molecular signature for antipsychotics and serms |
2015-6-25 |
2015-7-16 |
|
| Treatment of circadian rhythm disorders |
2015-1-31 |
2015-8-06 |
|
| Multiple myeloma treatment |
2014-8-22 |
2021-6-29 |
|
| Cancer treatment |
2014-8-22 |
2021-5-27 |
|
| Sensibilité de trichostatine a (tsa) dans le traitement de tumeurs |
2023-2-27 |
2023-9-07 |
|
| Melhora em um método para tratamento de pacientes com um distúrbio do sono … |
2020-2-13 |
2021-10-05 |
|